IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v43y2023i6p737-748.html
   My bibliography  Save this article

Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A Tutorial

Author

Listed:
  • Michael J. Sweeting

    (Statistical Innovation, AstraZeneca, Cambridge, UK)

  • Mark J. Rutherford

    (Department of Population Health Sciences, University of Leicester, UK)

  • Dan Jackson

    (Statistical Innovation, AstraZeneca, Cambridge, UK)

  • Sangyu Lee

    (Department of Population Health Sciences, University of Leicester, UK)

  • Nicholas R. Latimer

    (School of Health and Related Research, University of Sheffield, Sheffield, UK
    Delta Hat Limited, UK)

  • Robert Hettle

    (Health Economics and Payer Evidence, AstraZeneca, Cambridge, UK)

  • Paul C. Lambert

    (Department of Population Health Sciences, University of Leicester, UK
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden)

Abstract

Background Different parametric survival models can lead to widely discordant extrapolations and decision uncertainty in cost-effectiveness analyses. The use of excess hazard (EH) methods, which incorporate general population mortality data, has the potential to reduce model uncertainty. This review highlights key practical considerations of EH methods for estimating long-term survival. Methods Demonstration of methods used a case study of 686 patients from the German Breast Cancer Study Group, followed for a maximum of 7.3 y and divided into low (1/2) and high (3) grade cancers. Seven standard parametric survival models were fit to each group separately. The same 7 distributions were then used in an EH framework, which incorporated general population mortality rates, and fitted both with and without a cure parameter. Survival extrapolations, restricted mean survival time (RMST), and difference in RMST between high and low grades were compared up to 30 years along with Akaike information criterion goodness-of-fit and cure fraction estimates. The sensitivity of the EH models to lifetable misspecification was investigated. Results In our case study, variability in survival extrapolations was extensive across the standard models, with 30-y RMST ranging from 7.5 to 14.3 y. Incorporation of general population mortality rates using EH cure methods substantially reduced model uncertainty, whereas EH models without cure had less of an effect. Long-term treatment effects approached the null for most models but at varying rates. Lifetable misspecification had minimal effect on RMST differences. Conclusions EH methods may be useful for survival extrapolation, and in cancer, EHs may decrease over time and be easier to extrapolate than all-cause hazards. EH cure models may be helpful when cure is plausible and likely to result in less extrapolation variability. Highlights In health economic modeling, to help anchor long-term survival extrapolation, it has been recommended that survival models incorporate background mortality rates using excess hazard (EH) methods. We present a thorough description of EH methods with and without the assumption of cure and demonstrate user-friendly software to aid researchers wishing to use these methods. EH models are applied to a case study, and we demonstrate that EHs are easier to extrapolate and that the use of the EH cure model, when cure is plausible, can reduce extrapolation variability. EH methods are relatively robust to lifetable misspecification.

Suggested Citation

  • Michael J. Sweeting & Mark J. Rutherford & Dan Jackson & Sangyu Lee & Nicholas R. Latimer & Robert Hettle & Paul C. Lambert, 2023. "Survival Extrapolation Incorporating General Population Mortality Using Excess Hazard and Cure Models: A Tutorial," Medical Decision Making, , vol. 43(6), pages 737-748, August.
  • Handle: RePEc:sae:medema:v:43:y:2023:i:6:p:737-748
    DOI: 10.1177/0272989X231184247
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X231184247
    Download Restriction: no

    File URL: https://libkey.io/10.1177/0272989X231184247?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:43:y:2023:i:6:p:737-748. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.